Literature DB >> 8245526

Early abnormalities of the antibody response against Mycobacterium tuberculosis in human immunodeficiency virus infection.

C Saltini1, M Amicosante, E Girardi, G Antonucci, G Ippolito, F Ameglio, T Monno, P Congedo, G Angarano, S Babudieri.   

Abstract

Among human immunodeficiency virus (HIV)-infected persons, those who react against purified protein derivative (PPD) have higher risk of tuberculosis. Since PPD testing has limited predictive power in HIV-positive populations, new markers of antituberculous immunity were sought by analyzing antibodies to Mycobacterium tuberculosis antigens (PPD and its fraction A60) in 102 HIV-positive subjects, some PPD-positive and some PPD-negative, and in 23 HIV-positive tuberculosis patients. ELISA and Western blotting were used. Forty HIV-negative healthy subjects and 40 HIV-negative tuberculosis patients were evaluated as controls. While all those HIV-negative and PPD-positive had IgG antibodies recognizing the 38-, 28-, and 19-kDa M. tuberculosis antigens, only 26% of those HIV-positive and PPD-positive (all with < 400 CD4+ cells/mm3) and none of the HIV-positive tuberculosis patients recognized them, indicating that the lack of IgG against those antigens, in the presence of a specific IgM response, is a marker of immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245526     DOI: 10.1093/infdis/168.6.1409

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients.

Authors:  N Simonney; J M Molina; M Molimard; E Oksenhendler; C Perronne; P H Lagrange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-10       Impact factor: 3.267

2.  A toolbox for tuberculosis (TB) diagnosis: an Indian multi-centric study (2006-2008); evaluation of serological assays based on PGL-Tb1 and ESAT-6/CFP10 antigens for TB diagnosis.

Authors:  Philippe H Lagrange; Satheesh K Thangaraj; Rajeshwar Dayal; Alaka Deshpande; Nirmal K Ganguly; Enrico Girardi; Beenu Joshi; Kiran Katoch; Vishwa M Katoch; Manoj Kumar; Vemu Lakshmi; Marc Leportier; Christophe Longuet; Subbalaxmi V S Malladi; Deepali Mukerjee; Deepthi Nair; Alamelu Raja; Balambal Raman; Camilla Rodrigues; Pratibha Sharma; Amit Singh; Sarman Singh; Archana Sodha; Basirudeen Syed Ahamed Kabeer; Guy Vernet; Delia Goletti
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

3.  Evaluation of multi-antigen serological screening for active tuberculosis among people living with HIV.

Authors:  Devan Jaganath; Jayant Rajan; Christina Yoon; Resmi Ravindran; Alfred Andama; Lucy Asege; Sandra Z Mwebe; Jane Katende; Martha Nakaye; Fred C Semitala; Imran H Khan; Adithya Cattamanchi
Journal:  PLoS One       Date:  2020-06-04       Impact factor: 3.240

4.  Diagnosing latent tuberculosis infection in the HIV era.

Authors:  Philippe H Lagrange; Jean Louis Herrmann
Journal:  Open Respir Med J       Date:  2008-05-23

5.  HIV, HCMV and mycobacterial antibody levels: a cross-sectional study in a rural Ugandan cohort.

Authors:  Lisa Stockdale; Stephen Nash; Angela Nalwoga; Lorna Gibson; Hannah Painter; John Raynes; Gershim Asiki; Robert Newton; Helen Fletcher
Journal:  Trop Med Int Health       Date:  2018-12-27       Impact factor: 2.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.